Skip to main content

1 Result(s)

within Yoshiko Kamezaki Remove this filter

and

  1. Article

    A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma

    More information is needed regarding the efficacy of SARS-CoV-2 mRNA vaccines in immunocompromised populations, including patients with malignant lymphoma. This study aimed to evaluate humoral responses to the...

    Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki… in International Journal of Hematology (2023)

    Download PDF (842 KB) View Article